NEW YORK ( TheStreet) -- Par Pharmaceutical Companies (NYSE: PRX) hit a new 52-week high Thursday as it is currently trading at $37.03, above its previous 52-week high of $36.84 with 222,850 shares traded as of 12:57 p.m. ET. Average volume has been 412,800 shares over the past 30 days. Par Pharmaceutical Companies has a market cap of $1.32 billion and is part of the health care sector and drugs industry. Shares are up 12% year to date as of the close of trading on Wednesday. Par Pharmaceutical Companies, Inc., through its subsidiary, Par Pharmaceutical, Inc. engages in developing, licensing, manufacturing, marketing, and distributing generic and branded drugs in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter